TARS |
Tarsus Pharmaceuticals, Inc. |
Jun 17, 2024 |
3 |
-$287K |
4 |
Jun 20, 2024 |
Chief Financial Officer and Chief Strategy Officer |
TARS |
Tarsus Pharmaceuticals, Inc. |
Mar 7, 2024 |
2 |
$0 |
4 |
Mar 11, 2024 |
Chief Financial Officer and Chief Strategy Officer |
TARS |
Tarsus Pharmaceuticals, Inc. |
Apr 24, 2023 |
0 |
$0 |
3/A |
Apr 28, 2023 |
Chief Financial Officer and Chief Strategy Officer Exhibit 24 - Power of Attorney |
TARS |
Tarsus Pharmaceuticals, Inc. |
Apr 24, 2023 |
2 |
$0 |
4 |
Apr 26, 2023 |
Chief Financial Officer and Chief Strategic Officer |
GBT |
Global Blood Therapeutics, Inc. |
Oct 5, 2022 |
14 |
$0 |
4 |
Oct 6, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Sep 27, 2022 |
2 |
$388K |
4 |
Sep 29, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Sep 1, 2022 |
6 |
-$2.27M |
4 |
Sep 6, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Aug 1, 2022 |
4 |
-$68.9K |
4 |
Aug 3, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Mar 1, 2022 |
6 |
-$39.3K |
4 |
Mar 3, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Feb 1, 2022 |
5 |
-$132K |
4 |
Feb 3, 2022 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Sep 1, 2021 |
3 |
-$40.9K |
4 |
Sep 3, 2021 |
Chief Financial Officer |
GBT |
Global Blood Therapeutics, Inc. |
Aug 1, 2021 |
5 |
-$119K |
4/A |
Sep 24, 2021 |
Chief Financial Officer |